INS and myeloid sarcoma: Insulin levels increased in healthy individuals (mean: 9.3 to 14.9 μIU/mL; p = 0.051) and decreased in participants with MS (22.0 to 13.7 μIU/mL; p = 0.214), with a significant interaction effect (p = 0.020).